Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2011000124 - PHARMACEUTICAL COMPOSITION INCLUDING VIABLE PROBIOTIC STRAINS OF LACTOBACILLUS SPP. USED FOR THE PREVENTION AND RECOVERY OF INDIVIDUALS WITH URINARY TRACT INFECTIONS AND IMMUNOCOMPROMISED INDIVIDUALS

Publication Number WO/2011/000124
Publication Date 06.01.2011
International Application No. PCT/CL2010/000026
International Filing Date 02.07.2010
IPC
A61K 35/74 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
A61P 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 37/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
04Immunostimulants
CPC
A61K 35/74
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
A61P 13/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
02of urine or of the urinary tract, e.g. urine acidifiers
A61P 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 37/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
A61P 37/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
04Immunostimulants
Applicants
  • UNIVERSIDAD DE CONCEPCION [CL]/[CL] (AllExceptUS)
  • LABORATORIO PASTEUR [CL]/[CL] (AllExceptUS)
  • DURAPLAST LTDA. [CL]/[CL] (AllExceptUS)
  • SERVICIO SALUD CONCEPCION [CL]/[CL] (AllExceptUS)
  • CASTRO INOSTROZA, Erica [CL]/[CL] (UsOnly)
  • BORQUEZ YAÑEZ, Rodrigo [CL]/[CL] (UsOnly)
  • GONZALES RIQUELME, Margarita [CL]/[CL] (UsOnly)
  • AESCHLIMANN ARJONA, Valeska [CL]/[CL] (UsOnly)
Inventors
  • CASTRO INOSTROZA, Erica
  • BORQUEZ YAÑEZ, Rodrigo
  • GONZALES RIQUELME, Margarita
  • AESCHLIMANN ARJONA, Valeska
Agents
  • SEPULVEDA BARRERA, Ximena
Priority Data
1511-200902.07.2009CL
Publication Language Spanish (ES)
Filing Language Spanish (ES)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION INCLUDING VIABLE PROBIOTIC STRAINS OF LACTOBACILLUS SPP. USED FOR THE PREVENTION AND RECOVERY OF INDIVIDUALS WITH URINARY TRACT INFECTIONS AND IMMUNOCOMPROMISED INDIVIDUALS
(ES) FORMULACIÓN FARMACÉUTICA QUE INCORPORA CEPAS VIABLES PROBIÓTICAS DE LACTOBACILLUS SPP. Y QUE SE UTILIZA EN LA PREVENCIÓN Y RECUPERACIÓN DE INDIVIDUOS CON INFECCIÓN DEL TRACTO URINARIO Y EN INDIVIDUOS INMUNOCOMPROMETIDOS
(FR) FORMULATION PHARMACEUTIQUE QUI CONTIENT DES SOUCHES VIABLES PROBIOTIQUES DE LACTOBACILLUS SPP. ET QUI EST UTILISÉE DANS LA PRÉVENTION ET LE RÉTABLISSEMENT D' INDIVIDUS SOUFFRANT D'UNE INFECTION DU TRACTUS URINAIRE ET D'INDIVIDUS IMMUNOCOMPROMIS
Abstract
(EN)
The invention relates to technology which comprises a pharmaceutical formulation including dry biomass of viable probiotic strains of Lactobacillus spp., carriers and coadjuvants for the stability and survival of the microorganisms and to the use thereof in urinary tract infections, preferably of nosocomial origin, for preventive use before and after surgery in patients with urethral catheters and immunocompromised patients.
(ES)
La tecnología corresponde a una formulación farmacéutica que comprende biomasa seca de cepas viables probióticas de Lactobacillus spp., excipientes y coadyuvantes para Ia estabilidad y sobrevivencia de los microorganismos y un uso en infecciones del tracto urinario, preferentemente de origen nosocomial, preventiva pre y post cirugía en pacientes con sondas vesicales y en pacientes inmunocomprometidos.
(FR)
La technologie selon la présente invention correspond a une formulation pharmaceutique qui comprend de la biomasse sèche de souches viables probiotiques de Lactobacillus spp., des excipients et des coadjuvants pour la stabilité et la survie des microorganismes et correspond à une utilisation en cas d'infections du tractus urinaire, de préférence d'origine nosocomiale, de manière préventive, avant et après une chirurgie chez des patients équipés de sondes vésicales et chez des patients immunocompromis.
Latest bibliographic data on file with the International Bureau